Cargando…

Genetic polymorphisms, chronic lymphocytic leukemia, and the future: are we there yet?

Detalles Bibliográficos
Autores principales:	Caimi, Paolo F., de Lima, Marcos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Hematologia e Hemoterapia 2014
Materias:	Scientific comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3948656/ https://www.ncbi.nlm.nih.gov/pubmed/24624026 http://dx.doi.org/10.5581/1516-8484.20140003

Ejemplares similares

The treatment of acute lymphoblastic leukemia has come a long way but the best is yet to come
por: Chauffaille, Maria de Lourdes Lopes Ferrari
Publicado: (2013)

Myeloid leukemia: are we getting better?()
por: Hamerschlak, Nelson
Publicado: (2015)

Clostridium difficile infection is a frequent but well-controlled event after hematopoietic cell transplantation()
por: Caimi, Paolo Fabrizio
Publicado: (2015)

Yet another reason we need to tackle socioeconomic inequalities in smoking
por: Green, Michael J.
Publicado: (2022)

Successful treatment of chronic myeloid leukemia with tyrosine kinase inhibitors goes beyond access to drugs
por: Conchon, Monika
Publicado: (2013)

Utility of the p53 mutant protein in patients with low-risk myelodysplastic syndrome
por: Yao, David C., et al.
Publicado: (2014)

Hematopoietic stem cell transplantation for Hodgkin's disease
por: Patah, Poliana, et al.
Publicado: (2011)

BCR-ABL1 level monitoring in chronic myeloid leukemia by real time polymerase chain reaction in Brazil – not so real()
por: Pagnano, Katia Borgia Barbosa
Publicado: (2017)

Let us think about lymphocyte counts!
por: Hamerschlak, Nelson
Publicado: (2012)

Blood group polymorphisms in Brazil()
por: Castilho, Lilian
Publicado: (2016)

Molecular polymorphisms of human blood groups: a universe to unravel
por: de Mattos, Luiz Carlos
Publicado: (2011)

Comment on: Determination of serum levels of imatinib mesylate in patients with chronic myeloid leukemia: validation and application of a new analytical method to monitor treatment compliance
por: Simpson, David C
Publicado: (2013)

Hodgkin's lymphoma in developing countries: can we go further?()
por: Gaiolla, Rafael Dezen
Publicado: (2017)

Scientific comment on: “Analysis of imatinib adherence in chronic myeloid leukemia: a retrospective study in a referral hospital in the Brazilian Amazon”. Who likes to take medicine forever?()
por: Bendit, Israel
Publicado: (2019)

Compliance and adherence of patients in the treatment of acute lymphoblastic leukemia
por: Barr, Ronald Duncan
Publicado: (2011)

Pregnancy in sickle cell disease – do we know what to expect?()
por: Fertrin, Kleber Yotsumoto
Publicado: (2014)

Compound heterozygosity for hemoglobin S and D: what do we need to know?()
por: Bonini-Domingos, Claudia Regina
Publicado: (2016)

TP53 Mutations and Clinical Outcome in Chronic Lymphocytic Leukemia: Is a Threshold Still Needed?
por: Bomben, Riccardo, et al.
Publicado: (2023)

National neonatal screening program for hemoglobinopathies: how far have we advanced?()
por: da Fonseca, Silvana Fahel
Publicado: (2014)

DISCOVER: much accomplished, but not yet for all
por: Spiegel, Hans M L
Publicado: (2020)

A future without human leukocyte antigens?()
por: Gilli, Simone Cristina Olenscki
Publicado: (2018)

Metaphase cytogenetics and single nucleotide polymorphism arrays in myeloid malignancies()
por: da Silva, Fernanda Borges, et al.
Publicado: (2015)

Sickle cell disease: looking back but towards the future
por: Cançado, Rodolfo Delfini
Publicado: (2012)

Genetic evaluation of mesenchymal stem cells
por: Afonso Cornélio, Déborah, et al.
Publicado: (2014)

We need to talk more about transfusion-transmitted malaria in Plasmodium vivax endemic areas()
por: Lacerda, Marcus Vinícius Guimarães, et al.
Publicado: (2014)

Involvement of the cerebrospinal fluid cells in children with acute lymphoblastic leukemia: prognostic implications
por: Scrideli, Carlos Alberto
Publicado: (2012)

Genetic diversity of the human blood group systems
por: de Mattos, Luiz Carlos
Publicado: (2013)

ABO isohemagglutinin titration or hemolysin test: what should we do to reduce the risk of passive hemolysis?()
por: Castilho, Lilian
Publicado: (2015)

The expression of the CD56 antigen is associated with poor prognosis in patients with acute myeloid leukemia
por: Rego, Eduardo Magalhães
Publicado: (2011)

BCR-ABL rearrangement and HLA antigens: a possible link to leukemia pathogenesis and immunotherapy
por: Giunta, Marina, et al.
Publicado: (2012)

Comments on the evaluation of lymphocyte levels in a random sample of 218 elderly individuals from São Paulo city
por: Blomberg, Bonnie B., et al.
Publicado: (2011)

Induction therapy and stem-cell mobilization in myeloma, look at the past to plan the future()
por: Schaffel, Rony
Publicado: (2019)

Engineered and natural gene drives: mechanistically the same, yet not same in kind
por: Medina, Raul F., et al.
Publicado: (2023)

Comment on: “Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients”
por: Visentin, Andrea, et al.
Publicado: (2021)

Qualitative polymerase chain reaction versus quantitative polymerase chain reaction for the detection of minimal residual disease in children with acute lymphoblastic leukemia()
por: Scrideli, Carlos Alberto, et al.
Publicado: (2015)

Chemo-immunotherapy for Older Patients with Chronic Lymphocytic Leukemia – Passé Yet?
por: Danilov, Alexey V., et al.
Publicado: (2019)

Conditioning regimen using busulfan plus melphalan in hematopoietic stem cell transplantation: can this conditioning regimen be used in autologous or allogeneic transplantation for acute leukemia?
por: Lemoli, Roberto M., et al.
Publicado: (2011)

‘Leaky gut’ in hematological malignancies()
por: Costa-Lima, Carolina, et al.
Publicado: (2014)

Progress in chronic graft-versus-host disease
por: Martin, Paul J
Publicado: (2011)

Stressed ends: telomere attrition in chronic diseases()
por: Fok, Wilson Chun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ggbu6da0as54jal0okbj4iic2i